Skip to main content
. Author manuscript; available in PMC: 2014 Aug 11.
Published in final edited form as: Laryngoscope. 2009 May;119(5):924–932. doi: 10.1002/lary.20136

TABLE II.

Antibody Reactivity With Purified Sf9 rHuCTL2 P1 Protein Using Sera From UMHL Patients Negative For Antibody to a 68–72 kDa in Inner Ear Protein.

UMHL
Patient
No/sex/age		 rHuCTL2
binding		 Previous
WB Result* 		Previous
IF Result* 		Pretreatment*
PTA, R/L		 Post-treatment*
PTA, R/L		 Improvement
After
Corticosteroid* 		Type of
Hearing
Loss		 Side
Affected		 Other Autoimmune
Diseases
22/M/39* - - - 25/00 20/00 - Rapidly progressive Left -
23/F/65* - - - 25/28 25/22 - Rapidly progressive Bilateral -
Totals, N=2 0/2 0/2 0/2 0/2 None

UMHL = University of Michigan Hearing Loss; WB = western blot; IF = immunofluorescence; PTA = pure tone average; R = right; L = left; M = male; F = female

*

Previous tests as reported in Zeitoun et al. 200513